Connect with us

Press Release

ZUBR Has Become a Leader in the NMN Industry at Home and Abroad

Published

on

As the global economy continues to grow and life expectancy continues to rise, the proportion of elderly people aged 65 years and above continues to increase, and global attention to health issues continues to increase. The life expectancy issue has become one of the ultimate problems that mankind has continued to strive to solve in the history of mankind. In recent years, global academic research has shown that NMN has become a consensus anti-aging health care product.

The full name of NMN is β-nicotinamide mononucleotide, which is the precursor for the synthesis of NAD+ (coenzyme I) in the human body. Since NAD+ is a coenzyme for hundreds of important metabolic enzymes in cells, it also participates in many important cellular processes as a signal molecule. It is closely related to energy metabolism, glycolysis, DNA replication and other activities. NMN can increase the level of NAD+ in the body and is considered a health product with anti-aging functions. Compared with other products, NMN products enhance NAD+ and have the advantages of non-toxic side effects and high conversion efficiency. At present, the academic community has confirmed that NMN has the following 10 major functions: support NAD+ production (NAD+ is an indicator of aging in the body), activate longevity protein/gene SIRTUINS, repair DNA damage, support energy production, enhance metabolism, help enhance physical endurance and vitality, and helps improve blood vessel and muscle physiology, helps weight management, helps brain and heart health, helps improve insulin sensitivity, etc.

As one of the world-class academic achievements, Professor David Sinclair of Harvard University used NMN raw materials and published the research results of NAD+ reversing blood aging in the top academic journal “Cell”. From the age of 30, the NAD+ content in the body decreases significantly. At the age of 60, the level of NAD+ is less than a quarter of that of young people. This means that after 60 years of age, there are many biochemical and metabolic reactions in the human body that cannot be efficiently carried out. Therefore, the older the age, the more health problems become.

How to effectively supplement NMN? According to the FDA’s principle of equivalence, a 70Kg adult should be supplemented with 300mg of NMN per day, and an adult with the same amount of NMN needs to eat 32~128kg of edamame, or 54~240kg of broccoli. It is less efficient to supplement NMN through food sources in nature, and NMN products can achieve this effect faster. After taking NMN in the human body, the study found that the NAD+ content in the body increased significantly after 5 minutes, and the supplement effect was significantly improved.

ZUBR® from the United States is a high-tech company focusing on anti-aging research and product development for a long time. Headquartered in New York, USA, ZUBR® brand Slogan is Anti-aging From Young, advocating the life concept of “anti-aging while young”. ZUBR® introduces anti-aging explosives such as NMN to the United States, Europe and Asia, bringing a healthy lifestyle of “anti-aging while young” to hundreds of millions of middle-class people around the world. ZUBR® has the core production qualifications of health care products such as FDA, NSF GMP, and has mastered core production technology. According to the laboratory test results of US Pharmatech, ZUBR® NMN developed by biological enzymatic method has the characteristics of high purity, high absorption and conversion rate, and the effective purity is higher than that of products in the same industry.

At present, ZUBR® has many flagship products such as NMN Pro and NMN Honor, and the product line fully meets the needs of different users. Among them, the NMN Pro product comes in small bottles, which is currently the only product on the market with a weekly pack (14 capsules) as a unit, which is especially suitable for urban white-collar people to carry during their daily commuting. Each bottle of NMN Pro contains 14 high-concentration NMN capsules, which can be used for a week, and each time it is taken, it can supplement 340mg NMN and 100mg resveratrol. NMN Honor provides a more powerful dose of NMN, suitable for reuse in the morning at home. It can supplement 480mg of NMN and 100mg of resveratrol each time. Each bottle provides 90 capsules for 45 days of continuous use.

Overseas, ZUBR® has won praise from a large number of users with its excellent product strength. Bryan Gunn, an automotive industry designer from Ohio, USA, said, “After taking it, I feel my body is full of vitality, my sleep quality has unexpectedly improved, and I feel my mind is clearer”. Dean Norris, a fund manager from Wall Street in New York, United States, said, “Day 1: 2 capsules in the morning, the body has a significant reaction in the afternoon, and fatigue is reduced; Day 2: 2 capsules in the morning, I feel more clear-headed; 4, 5 days: One hour after each consumption, you can feel your mind becomes clearer and no longer tired; 6th and 7th days: More energy and weight loss than before.” Peter Gould, a Java development engineer from California, said, “Since taking it, I have been very stable and sustained vitality throughout the day. This is an experience I haven’t had before trying other health foods.”

ZUBR® officially entered the Asian market in 2019, using word of mouth as the lifeline of the company’s survival and development. At the same time, in combination with the actual needs of the Asian market, the product price is reduced to a level that can be purchased by the general public while meeting the effective dose. We have reason to believe that ZUBR® will soon become the leading brand in the field of anti-aging health food.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Wellows Launches AI Search Visibility Platform for Agencies and Startups

Published

on

As AI search becomes the front door to discovery, Wellows helps agencies & startups control how their brands appear, perform, and are referenced inside AI-generated answers

Dubai, United Arab Emirates, 16th Feb 2026 – Wellows today announced the launch of the Wellows AI Search Visibility Platform, built for agencies and startups that need to understand and manage how they show up across AI-powered search and answer engines.

AI-driven answer experiences are changing how brands get found, and teams now face new execution challenges: identifying where brands are mentioned (and where they are missing) in AI generated answers, and how representation changes over time. Agencies also need a scalable way to translate AI visibility into consistent client communication.

“Agencies don’t just need another SEO tool, they need clarity across multi-client work, content strategy, outreach, and performance history,” said Masab Gadit, Founder and CEO at Wellows. “That’s exactly what we set out to solve with Wellows. Wellows is an autonomous marketing platform built to help agencies and startups monitor their AI visibility and turn those insights into workflows that help your team plan smarter, execute faster, and report clearly.”

Challenges Addressed

  • Brand mention visibility in AI generated answers: Visibility into where brands appear, when they do not, and how they are represented.
  • Outreach prioritization: Clearer signals to guide outreach and content efforts connected to AI visibility.
  • Agency reporting at scale: They need faster, repeatable reporting across multiple clients without manual checking.
  • Performance changes over time: Historical context to compare results and track progress.

Launch Features

Here’s a quick look at the features:

  • Wellows Outreach: Supports outreach planning by surfacing where brands are mentioned (and missing) in AI generated answers, helping teams prioritize outreach and content around visibility gaps and opportunities.
  • Historical Performance Monitoring & Comparison: Enables teams to monitor changes in AI visibility over time and compare performance across time periods, clients, or categories to understand progress and direction.
  • Client Reporting: Provides client-ready reporting that agencies can use to communicate visibility, progress, and changes over time in a consistent format across accounts.
  • Team Invites: Allows to collaborate by inviting colleagues and stakeholders into the platform, supporting shared visibility and coordinated execution.
  • API & Integrations: Wellows integrates with Google Search Console, provides an API for client reporting, and offers a WordPress integration that lets you send and draft blog posts directly, so it fits seamlessly into your team’s existing workflow.

Availability

The Wellows AI Search Visibility Platform is available now. To learn more, visit wellows.com.

About Wellows

Wellows is an AI search visibility platform that helps agencies, startups, and SMEs understand and control how they appear in AI generated answers. As AI reshapes discovery, Wellows equips teams to manage representation, protect narrative accuracy, and improve performance inside AI search.

Users can follow Wellows on:

LinkedIn: https://www.linkedin.com/company/wellowsofficial/

YouTube: https://www.youtube.com/@Wellows-Official

Media Contact

Organization: Wellows

Contact Person: Masab Gadit

Website: https://wellows.com/

Email:
media@wellows.com

Contact Number: +971557375697

Address:A1-UG-001, IFZA Dubai – Building A1, Dubai Silicon Oasis

City: Dubai

Country:United Arab Emirates

Release id:41343

The post Wellows Launches AI Search Visibility Platform for Agencies and Startups appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

3rd Iraqi Medical Conference Concludes in Dubai

Published

on

Dubai, UAE, 16th February 2026, The 3rd Iraqi Medical Conference and BAU Awards Ceremony successfully concluded in Dubai on 14th February 2026, drawing more than 1,000 participants from the United Arab Emirates and across the globe.

Dr. Falah Al Khatib, Vice President of the Emirates Oncology Society presented with the Lifetime Achievement Award

Held for the third consecutive year in Dubai, the conference brought together a distinguished gathering of Emirati, Iraqi, and international physicians across all medical specialties, in addition to dentists, pharmacists, healthcare providers, medical and pharmaceutical industry professionals, medical and health sciences students, academics, researchers, and innovators.

Among the most distinguished honorees was Dr. Falah Al Khatib, Vice President of the Emirates Oncology Society and Senior Consultant Clinical Oncologist at Al Zahra Hospital – UAE, and Member of the Advisory Board and BAU Award Committee, who was presented with the Lifetime Achievement Award in recognition of his remarkable career and significant contributions to advancing oncology services and elevating medical practice at both regional and international levels.

The award reflected deep appreciation for the leadership and impact of UAE-based medical professionals who continue to set benchmarks in excellence, innovation, and humanitarian commitment.

The strong participation from the UAE’s medical community underscored the depth of scientific collaboration and professional partnership between Iraqi healthcare professionals and their Emirati counterparts. The event further highlighted the UAE’s continued role as a regional and global hub for medical innovation, research excellence, and international scientific exchange.

Over two dynamic days, participants explored the latest advancements in medical science, presented pioneering research, and shared advanced clinical experiences led by prominent Iraqi and international experts. The conference served not only as a scientific forum but also as a strategic platform for strengthening professional networks and fostering cross-border healthcare collaboration.

Dubai’s position as a world-class destination that seamlessly combines progress, hospitality, and innovation once again reinforced its standing as a premier host city for major international scientific gatherings.

A key highlight of the event was the BAU Awards Ceremony, which recognized outstanding medical professionals for their scientific, clinical, and humanitarian contributions.

The conference concluded with reaffirmed commitment to hosting the event annually in Dubai, further strengthening its role as a global platform uniting Iraqi, Emirati, Arab, and international healthcare leaders. Organizers emphasized the importance of sustained collaboration, knowledge exchange, and recognition of excellence as essential pillars for shaping a more innovative and sustainable future for healthcare.

The 3rd Iraqi Medical Conference and BAU Awards Ceremony stands as a testament to the power of scientific unity and shared vision in advancing healthcare across borders.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

When Gatekeepers Exploit the Public Markets: How Aggressive Micro-Cap Structuring Ruined It for Everyone

Published

on

The micro-cap IPO window did not close by accident. It did not shut because investors suddenly lost interest in growth companies, nor because capital vanished from the system. It narrowed because structural flexibility was pushed too far, for too long, and in ways that ultimately forced a response.

Between 2021 and 2025, U.S. IPO activity moved through distinct but related phases, with a meaningful share concentrated in small and micro-cap offerings. The early part of that period was marked by abundant liquidity and elevated risk appetite. Capital was readily available, speculative enthusiasm was high, and smaller issuers found receptive audiences. As broader market conditions tightened — rising rates, declining valuations, and more selective institutional capital — access became more constrained. But micro-cap deal activity did not disappear. Instead, structures became more complex, more aggressive, and in some cases more dependent on volatility itself to sustain capital formation.

Many of these offerings raised under $50 million. Some were far smaller. On the surface, the activity suggested that emerging companies still had viable pathways into the public markets even as larger IPO windows fluctuated. It appeared to represent resilience at the smallest tier of the exchange ecosystem.

But beneath that surface, structural vulnerabilities were becoming increasingly visible.

Low public float, thin liquidity, layered financing instruments, and capital structures highly sensitive to short-term trading dynamics created an environment where price spikes were common and reversals were swift. In some instances, the very features that made entry possible also amplified instability after listing. Retail investors frequently entered during upward momentum, only to encounter dilution cycles and sharp corrections once financing mechanisms were triggered.

By 2024 and into 2025, the pattern was difficult to ignore. When volatility-dependent structures repeat across multiple issuers and produce similar outcomes, exchanges and regulators inevitably respond.

To understand why the window narrowed, it is necessary to examine how certain gatekeepers operated during this multi-year cycle.

 

Why This Needs to Be Said

Much of this is acknowledged privately among market professionals but rarely articulated openly. The tightening of the micro-cap IPO market did not occur in isolation. It followed several years in which structural flexibility was tested — and in some cases stretched — to the outer edge of what the public markets would absorb.

When deal structures prioritize maximum short-term extraction over long-term durability, the consequences extend well beyond any single transaction. The ripple effects are systemic.

Legitimate small-cap companies that genuinely seek to use public markets for growth now face higher barriers because flexibility that once existed was leaned on too aggressively. Retail investors who want exposure to early-stage stories have grown more skeptical — understandably — after repeated volatility cycles that ended in heavy dilution and sharp declines. And securities attorneys who operate ethically, structure balanced offerings, and prioritize sustainable capital formation now work within a framework shaped by reforms triggered by more aggressive actors.

This is not an indictment of an entire profession. There are capable, principled attorneys who protect issuers and investors alike. But when a segment of the market exploits structural weaknesses — whether through excessively dilutive terms, volatility-sensitive financing, or capital raises timed around artificial momentum — the regulatory response applies broadly. It does not isolate the careful from the careless.

 

Exploiting the Structure of Micro-Cap Markets

Securities attorneys and placement professionals play a central role in shaping capital formation. They structure offerings, negotiate financing terms, design warrant packages, and guide issuers through public listings. When executed responsibly, this work strengthens market integrity and protects both issuers and investors.

During the 2021–2025 cycle, however, some market participants leaned heavily into vulnerabilities inherent in the smallest tier of the public markets.

Deeply discounted offerings layered onto thin floats. Highly dilutive convertible instruments structured to benefit from volatility. Heavy warrant coverage tied to elevated trading windows. Capital raises executed during price surges rather than tied to operational milestones.

This did not describe every firm or every transaction. Many advisors insist on durable, balanced structures. But in competitive environments, issuers under financial pressure gravitate toward the most permissive structure available. If one advisor is willing to push further — offering fewer constraints and more aggressive economics — the incentives become self-reinforcing.

Businesses generally pursue the structure that raises the most capital under the least restrictive terms. When thin float, retail momentum, and volatility can be leveraged to maximize proceeds, the temptation is obvious.

The outcomes, over time, became predictable.

 

The Volatility–Offering Cycle

In a low-float environment, even modest buying pressure can send a stock materially higher. Add promotional energy — optimistic press releases, speculative commentary, retail enthusiasm — and price discovery can detach from fundamentals with surprising speed.

A familiar sequence often followed: a sharp upward move; an offering or capital raise executed near elevated levels; warrant exercises or conversions; significant dilution; and then a rapid reversal as new supply overwhelmed demand.

Retail investors frequently entered during the surge, believing the move reflected genuine operational progress or transformative developments. In many cases, disclosures were technically compliant but structurally incomplete in terms of explaining how financing mechanics would affect shareholders during inevitable volatility.

When the reversal came — as thinly traded micro-caps often experience — retail participants were left holding losses amplified by capital structures designed to reset, reprice, or convert during weakness.

The issue was not geography. It was not limited to foreign issuers. U.S.-based micro-caps have exhibited similar cycles across decades. The common denominator was structure — and how that structure was used.

 

PIPE Financing: When a Tool Becomes a Weapon

Private Investment in Public Equity (PIPE) financings were originally intended as efficient capital formation tools. In principle, they allow public companies — particularly smaller issuers — to raise capital quickly without undertaking a full public offering. When structured responsibly, PIPEs can provide flexibility to companies navigating early growth phases.

But during the multi-year micro-cap cycle, these instruments were at times engineered in ways that diverged sharply from that purpose.

Deep discounts, floating-rate convertibles, reset provisions tied to future trading prices, and heavy warrant coverage can create incentives fundamentally misaligned with long-term shareholders. In thin-float securities, these features can produce a self-reinforcing loop: volatility attracts financing; financing introduces dilution; dilution pressures price; conversion formulas reset lower; and the cycle continues.

The structure becomes volatility-dependent.

This is not a blanket condemnation of PIPE transactions. Many are negotiated fairly and disclosed transparently. The concern arises when financing instruments are repeatedly designed in ways that appear to benefit from predictable dilution and instability — particularly in companies with limited operating scale.

Public markets tolerate dilution when it funds growth. They do not function well when financing mechanics depend on volatility and repeated resets to generate return.

When sophisticated professionals structure or facilitate such transactions repeatedly — especially where patterns become visible across multiple issuers — fines alone are unlikely to alter behavior. Monetary settlements absorbed as a cost of doing business do not deter systemic exploitation.

In cases involving intentional misrepresentation, undisclosed conflicts, coordinated dilution cycles, or market manipulation, consequences should extend beyond financial penalties. Industry bars, professional discipline, and — where evidence supports it — prosecution are not excessive measures. They are necessary protections.

Gatekeepers exist because markets rely on professionals to prevent predictable harm. When they instead enable it, meaningful accountability is essential.

 

Why Exchanges Responded

Exchanges did not tighten standards based on theory. They responded to observable fragility accumulated over several years.

Listing thresholds increased. Requirements surrounding unrestricted publicly held shares became more demanding. Continued listing standards — including minimum bid price and market value thresholds — were enforced more rigorously. Exchanges expanded qualitative discretion where structural concerns suggested heightened manipulation risk.

The entry threshold rose. The survival threshold rose. Ultra-thin, volatility-dependent pathways became significantly more difficult to execute.

From a systemic perspective, the shift is understandable. Markets cannot function if confidence erodes at their foundation. But the tightening did not isolate only aggressive actors. It reshaped the environment for everyone operating within it.

The Collateral Consequences

When structural flexibility is exploited repeatedly, corrective responses are rarely surgical.

Legitimate small companies now face higher capital barriers. Responsible advisors operate in a more restrictive framework. Retail investors approach micro-cap growth stories with heightened skepticism. The ecosystem adjusts collectively.

That is the quiet cost of exploitation.

The Larger Lesson

Public markets are sustained not only by disclosure, but by structure. When companies are engineered in ways that rely on volatility to raise capital, when financing mechanics amplify dilution during price spikes, and when retail investors repeatedly absorb asymmetric downside, confidence deteriorates.

Micro-cap IPOs still exist. Access has not disappeared. But it is no longer as permissive as it once was.

That shift was not random. It was the product of incentives pushed too far over a multi-year cycle — and structures leaned on too heavily.

Integrity sustains access.

Exploitation, eventually, closes the window for everyone.

Media Contact: 

Matt Miller
Strategic Risk LLC
Bronx
NY
United States
9143064771

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST